EW vs PATH
Edwards Lifesciences Corp (EW) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
EW currently screens at market cap $49.91B and trailing P/E 46.9. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the EW and PATH stock pages for the full models.
Not investment advice.